NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,876,761 | -11.1% | 155,407 | +11.6% | 0.00% | -25.0% |
Q2 2023 | $7,731,881 | 0.0% | 139,263 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $7,731,881 | +38.6% | 139,263 | +0.2% | 0.00% | +33.3% |
Q4 2022 | $5,580,255 | -99.9% | 138,916 | +19.2% | 0.00% | 0.0% |
Q3 2022 | $5,105,512,000 | +1.9% | 116,511 | -17.6% | 0.00% | 0.0% |
Q2 2022 | $5,011,855,000 | -67.5% | 141,418 | -62.7% | 0.00% | -57.1% |
Q1 2022 | $15,434,725,000 | -57.2% | 379,418 | -1.7% | 0.01% | -50.0% |
Q4 2021 | $36,030,236,000 | -7.2% | 385,804 | +10.7% | 0.01% | -12.5% |
Q3 2021 | $38,825,696,000 | -14.1% | 348,400 | -12.5% | 0.02% | -15.8% |
Q2 2021 | $45,214,344,000 | +18.6% | 398,259 | +6.1% | 0.02% | +11.8% |
Q1 2021 | $38,126,240,000 | -23.1% | 375,480 | -24.6% | 0.02% | -26.1% |
Q4 2020 | $49,589,520,000 | +41.9% | 498,287 | +3.0% | 0.02% | +21.1% |
Q3 2020 | $34,952,673,000 | +44.2% | 483,841 | -0.5% | 0.02% | +26.7% |
Q2 2020 | $24,241,384,000 | +41.9% | 486,189 | -15.0% | 0.02% | +25.0% |
Q1 2020 | $17,080,964,000 | -14.6% | 572,035 | -3.7% | 0.01% | 0.0% |
Q4 2019 | $20,012,803,000 | +16.3% | 594,028 | +13.2% | 0.01% | 0.0% |
Q3 2019 | $17,214,949,000 | +21.4% | 524,846 | +2.1% | 0.01% | +20.0% |
Q2 2019 | $14,182,353,000 | +108.1% | 514,226 | +55.6% | 0.01% | +100.0% |
Q1 2019 | $6,814,601,000 | +4036.9% | 330,485 | +2700.7% | 0.01% | – |
Q4 2018 | $164,728,000 | -41.7% | 11,800 | 0.0% | 0.00% | – |
Q3 2018 | $282,492,000 | +168050.0% | 11,800 | -21.9% | 0.00% | – |
Q3 2016 | $168,000 | -7.7% | 15,100 | 0.0% | 0.00% | – |
Q2 2016 | $182,000 | – | 15,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |